Product
Vehicle Patch
1 clinical trial
3 indications
Indication
Verruca VulgarisIndication
WartsIndication
Common WartClinical trial
Protocol 250-1951-201: A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of VDMN-21 in Subjects With Verruca VulgarisStatus: Recruiting, Estimated PCD: 2024-06-01